Barbara Weber, M.D.

Barbara Weber, M.D.

DirectoratTango Therapeutics· In proxies 2022–2025

Pay in FY2024+93% from the year before · Tango Therapeutics stock -68.8% the same year

Barbara Weber, M.D. was paid $6.5M in FY2024 (Dec), up 93%. Tango Therapeutics stock fell 68.8% that year.

Pay$100 in the stock at the end of FY21 → $28
Pay is from the Summary Compensation Table of each Tango Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Revolution MedicinesPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  2. Tango TherapeuticsPublic company · 4 yr
    • President, Chief Executive Officer and Director2022 – Present · 4 yrStock in role +107%
  3. FOG PharmaPublic company · 8 yr
    • Director2018 – Present · 8 yrNo stock prices for these years
  4. OPY Acquisition CorpPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?